Innsbruck, Austria

Najib Maslouh

This inventor holds 1 USPTO granted patent. Top assignee: C-Chem Ag. Active years: 2003.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Najib Maslouh. Retrieved from https://idiyas.com/inventor/najib-maslouh

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 21(Granted Patents)


Company Filing History:


Years Active: 2003

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovator Spotlight: Najib Maslouh in Innsbruck, Austria

Introduction

Najib Maslouh is an accomplished inventor based in Innsbruck, Austria. He has made significant contributions to the field of pharmaceuticals, particularly with his innovations in cyclosporins. His work demonstrates a commitment to advancing healthcare technology.

Latest Patents

Najib Maslouh holds a notable patent related to cyclosporins, which are vital in the medical field for their immunosuppressive properties. This patent reflects his innovative approach and understanding of complex biochemical compounds.

Career Highlights

Currently, Najib is associated with C-Chem Ag, a company dedicated to chemical and pharmaceutical innovations. His work in this dynamic environment allows him to explore new ideas and develop groundbreaking solutions in the industry.

Collaborations

Najib has collaborated with esteemed colleagues Ernst Ellmerer-Müller and Dagmar Brössner. These partnerships foster an environment of creativity and innovation, enhancing the impact of his work in the field.

Conclusion

Najib Maslouh continues to make strides in the world of inventions and patents, especially within the realm of pharmaceuticals. His dedication to innovation and collaboration sets a standard for aspiring inventors in Austria and beyond. His contributions are paving the way for advancements that can significantly benefit healthcare and patient outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…